MILES' GLUCOBAY FOR DIABETES NOT RECOMMENDED FOR APPROVAL: CMTE. CITES LACK OF CLINICAL EFFICACY AND LONG-TERM USE DATA AS WELL AS LIVER TOXICITY POTENTIAL

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".